125 results
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
12 Mar 24
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
7:42pm
in gathering clinical evidence relative to the safety and performance of the test and also providing data that will potentially support payer reimbursement
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
8 Nov 23
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
5:14pm
BarreGEN to assist us in gathering clinical evidence relative to the safety and performance of the test and also providing data that will potentially support
8-K
EX-99.1
p6pws7 lxeryyjt
9 Aug 23
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
3:47pm
8-K
EX-10.1
7y3v0wwklqs8r
1 Aug 23
Departure of Directors or Certain Officers
8:59pm
8-K
EX-99.1
pa93mo 9gr9biegzpsh
12 May 23
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
4:34pm
8-K
EX-99.1
hs6pzc5rlex
14 Nov 22
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results
4:52pm
8-K
EX-10.1
8hkh35 o8ad3i2meh
4 Oct 22
Departure of Directors or Certain Officers
4:18pm
8-K
EX-10.1
mdjuo4fn0yxeyky4mz4
7 Sep 22
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
f16x9 b3yw5942tx0
7 Sep 22
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-2.1
ors 5ux62
7 Sep 22
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
fv2grcrpix4bug5zo5fl
15 Aug 22
Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results
5:42pm